Final Results Presented in Late-Breaking Session at Society for Vascular Surgery 2019 Vascular Annual Meeting NATIONAL HARBOR, Maryland – June 15, 2019 – Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced positive final results for the company’s […]
Peripheral/Endo
TCAR Achieves Favorable Outcomes vs. Carotid Endarterectomy in Patients with Carotid Artery Disease
Updated Results of TCAR Surveillance Project Presented at Society for Vascular Surgery Vascular Annual Meeting NATIONAL HARBOR, Md., June 13, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the presentation of real-world data for the […]
Cardiovascular Systems, Inc. Announces First Patient Enrolled in REACH PVI Clinical Study
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the first patient was enrolled in the REACH PVI study. The purpose of this study is to prospectively evaluate acute […]
Endologix Announces Reinstatement of CE Mark for its Nellix EndoVascular Aneurysm Sealing System
IRVINE, Calif.–(BUSINESS WIRE)–Endologix® Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the EC Certificate of Conformity (CE Mark) for the Nellix EndoVascular Aneurysm Sealing System (Nellix System) has been reinstated by GMED, the EU Notified Body for the Nellix System. The reinstatement […]
Silk Road Medical Announces Key TCAR Presentations at the Society for Vascular Surgery 2019 Vascular Annual Meeting
Results Include Data from SVS TCAR Surveillance Project and ROADSTER-2 Study SUNNYVALE, Calif. – June 4, 2019 – Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key data from the SVS TCAR Surveillance Project and ROADSTER-2 study […]
FLEX Vessel Prep™ System Data Presented at New Cardiovascular Horizons Conference Shows Key Findings including Luminal Gain
TOLEDO, Ohio, June 4, 2019 /PRNewswire/ — VentureMed Group, Inc., a privately-held medical device innovator in vessel preparation for interventional treatment of peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced new data presented at the 20th Annual New Cardiovascular Horizons (NCVH) Annual Conference, May 29-31, in New Orleans, Louisiana. FLEX iDissection Study Results Presentation The study […]
Safety and efficacy of Philips’ Stellarex .035 low-dose drug-coated balloon demonstrated in clinical trials at three years
Stellarex is the only low-dose [1] drug-coated balloon (DCB) to demonstrate a significant treatment effect and high safety profile through 3 years ILLUMENATE Pivotal trial showcases durable primary patency (maintained blood flow) in the most complex patient pool studied in a DCB randomized clinical trial No significant difference in mortality […]
Proximo Medical Selected as Commercialization Partner for Walk Vascular
CASTLE PINES, Colo., May 28, 2019 /PRNewswire/ — Proximo Medical today announced that it has been selected as the marketing and commercial partner for Walk Vascular, an innovative medical device company that has developed JETi, a novel Peripheral Thrombectomy Catheter. Proximo Medical is a fractional commercial organization for start-up medical device technologies that delivers market […]
DABRA Laser to be Presented as a Frontline Therapy for CLI at the 2019 SCAI Scientific Sessions
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED) today announced that Dr. Mohammad Ansari will present DABRA as a treatment for critical limb ischemia (CLI) during a scientific case review May 21 at the SCAI annual meeting in Las Vegas. “The unique DABRA catheter and laser system is a highly effective frontline […]
Intact Vascular to Sponsor Post-Angioplasty Dissection Symposium at 2019 New Cardiovascular Horizons Conference
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations to be featured during a lunch symposium at the 2019 New Cardiovascular Horizons (NCVH) Conference, May 29th through 31st at The Roosevelt New Orleans in New Orleans, Louisiana. Recently FDA-approved […]



